companies innovating obesity treatment glp-1 drugs 2025 Potential Emerging Therapies in the Space Nutritional priorities to support GLP-1

Description

There was an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, nephrolithiasis, interstitial nephritis and drug-induced pancreatitis.

It helps maintain gut health, support metabolic performance, and promote immune and internal balance over time.

Despite their exploding popularity, the current GLP-1 injections (semaglutide though is also orally available) face accessibility issues due to cost and adverse effects and thus the next big move for the space, an easy to - pop pill could be lucrative, for which clinical trials are already well underway

GLP-1 shots are clinically proven to be the most effective option for weight loss and blood sugar control.

These milestones will redefine how obesity care is delivered, marking a turning point that will shape the markets trajectory for 2026 and the years to come